Browne Frederick A, Clark Cathy, Bozdogan Bülent, Dewasse Bonifacio E, Jacobs Michael R, Appelbaum Peter C
Department of Medicine, Hershey Medical Center, 500 University Drive, PA 17033, USA.
Int J Antimicrob Agents. 2002 Aug;20(2):93-9. doi: 10.1016/s0924-8579(02)00120-6.
Attempts were made to select resistant pneumococcal mutants by sequential subculturing of 12 clinically isolated pneumococci, [four were penicillin sensitive (MIC) 0.03-0.06 mg/l, four penicillin intermediate (MIC 0.25-0.5 mg/l) and four penicillin resistant (MIC 2-4 mg/l)] in sub-inhibitory concentrations of ceftriaxone, levofloxacin, gatifloxacin and moxifloxacin. Subculturing in gatifloxacin, levofloxacin, moxifloxacin and ceftriaxone selected 12 mutants (12/12), 10 mutants (10/12), 10 mutants (10/12) and three mutants (3/12), respectively. DNA sequencing of the quinolone-resistant mutants showed that most strains had mutations in GyrA at E85 or S81. This in vitro mutation study demonstrates a clear distinction between the low frequency of development of resistance with ceftriaxone exposure as opposed to the high frequency with quinolone exposure.
通过对12株临床分离的肺炎球菌进行连续传代培养,尝试筛选出耐药肺炎球菌突变体,[其中4株对青霉素敏感(MIC为0.03 - 0.06mg/l),4株对青霉素中介(MIC为0.25 - 0.5mg/l),4株对青霉素耐药(MIC为2 - 4mg/l)],传代培养使用的是低于抑菌浓度的头孢曲松、左氧氟沙星、加替沙星和莫西沙星。在加替沙星、左氧氟沙星、莫西沙星和头孢曲松中传代培养分别筛选出12个突变体(12/12)、10个突变体(10/12)、10个突变体(10/12)和3个突变体(3/12)。对喹诺酮耐药突变体进行DNA测序表明,大多数菌株在GyrA的E85或S81处发生了突变。这项体外突变研究表明,与喹诺酮暴露导致的高耐药频率相反,头孢曲松暴露导致耐药产生的频率较低,两者之间存在明显差异。